Insiders · Profile

Yoshiyama Annie

SVP, Finance at Allogene Therapeutics. Filing since 21 Apr 2025. CIK 0001835208

Company

Date

Role

Action

Shares

Amount

Of holding

ALLO Allogene Therapeutics, Inc.

21 Apr 2026

SVP, Finance

Sold at will

9,586

$22.14K

7.1%

ALLO Allogene Therapeutics, Inc.

2 Feb 2026

SVP, Finance

Sold at will

4,167

$7.17K

3.1%

ALLO Allogene Therapeutics, Inc.

21 Apr 2025

SVP, Finance

Sold at will

9,601

$13.54K

6.8%

3 decisions on file.